Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Elutia Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target
Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Cantor Fitzgerald Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Elutia Analyst Ratings
Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains Buy on Elutia, Raises Price Target to $10
Cantor Fitzgerald Maintains Overweight on Elutia, Raises Price Target to $11
Elutia Analyst Ratings
Cantor Fitzgerald Maintains Overweight on Elutia, Raises Price Target to $11
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $5
Elutia Analyst Ratings
Strong Buy Rating for Elutia Amid Anticipated FDA Clearance and Robust Product Growth
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $6
Elutia Analyst Ratings
Elutia Analyst Ratings
No Data
No Data